Treace Medical Concepts, Inc. (TMCI)

Nasdaq: TMCI · Surgical & Medical Instruments & Apparatus · Ponte Vedra, FL · filing with the SEC since 2015

Full chart Alerts Compare

Grade5.6

◀ Past 7.1● Present 5.7▶ Future 4.0

1 est.

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

Who owns Treace Medical Concepts, Inc.

As filed with the SEC

Holders of 5% or more

John T. Treace holds 19.2% of Common Stock, $0.001 par value, as its SCHEDULE 13G/A filed Aug 12, 2026 says.

Directors and officers

report now, of 22 people on the record since 2021. Their holdings as a group are not read here.

Institutions as a whole

n/a

The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 4 named at left.

Holders of 5% or moreshare of the class, as filed

John T. Treace

SCHEDULE 13G/A · filed Aug 12, 2026 · Common Stock, $0.001 par value

19.2%

Armistice Capital, LLC

SCHEDULE 13G/A · filed Aug 14, 2026 · Common stock, $0.001 par value · 9.85% in May 15, 2026

9.79%

Neil Gagnon

SCHEDULE 13G/A · filed Feb 12, 2026 · Common stock, $0.001 par value · 6.3% in May 15, 2025

9.6%

Bank of America Corporation

SCHEDULE 13G · filed May 14, 2026 · Common Stock

5.5%

Morgan Stanley

SCHEDULE 13G/A · filed Feb 3, 2025 · Common Stock · reported falling below 5%

under 5%

William Blair Investment Management, LLC

SCHEDULE 13G/A · filed Feb 9, 2026 · Common Stock · reported falling below 5%, from 5.8% in Nov 12, 2025

under 5%

Blackrock, Inc.

SCHEDULE 13G/A · filed Jul 30, 2026 · Common Stock · reported falling below 5%

under 5%

What TMCI reports owning in othersstakes of 5% or more, and other ties

Other ties the annual report names

RedPoint Medical3D

A company bought · acquisition · owns, named in the 10-K filed Feb 27, 2026

Insider tradesForm 4

0sales

14purchases

0sales on a scheduled plan

0people selling

$0sold, in dollars

$1.5Mbought, in dollars

Open-market trades on Form 4 from Oct 28, 2025 to Oct 28, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.

By calendar yearSoldBought

212223242526

2026 runs to Oct 28, 2026. Dollars as filed, summed by the transaction date.

People who traded in the window1 of 22 on the roster

Person	Role as filed	Sales	Sold	On a plan	Buys	Bought
Treace John T.	Chief Executive Officer	0	$0	0	14	$1.5M

SI Assistanton TMCI · research, not advice